Friday, October 28, 2016

Dermex




Dermex may be available in the countries listed below.


Ingredient matches for Dermex



Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Dermex in the following countries:


  • Bangladesh

International Drug Name Search


Feldene


Feldene is a brand name of piroxicam, approved by the FDA in the following formulation(s):


FELDENE (piroxicam - capsule; oral)



  • Manufacturer: PFIZER

    Approval date: April 6, 1982

    Strength(s): 10MG [AB], 20MG [RLD][AB]

Has a generic version of Feldene been approved?


Yes. The following products are equivalent to Feldene:


piroxicam capsule; oral



  • Manufacturer: MUTUAL PHARM

    Approval date: March 12, 1993

    Strength(s): 10MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 31, 1992

    Strength(s): 10MG [AB], 20MG [AB]


  • Manufacturer: NOSTRUM LABS

    Approval date: June 15, 1993

    Strength(s): 10MG [AB], 20MG [AB]


  • Manufacturer: TEVA

    Approval date: December 11, 1992

    Strength(s): 10MG [AB], 20MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: September 29, 1995

    Strength(s): 10MG [AB], 20MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: May 16, 1996

    Strength(s): 10MG [AB], 20MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Feldene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Feldene.

See also...

  • Feldene Consumer Information (Wolters Kluwer)
  • Feldene Consumer Information (Cerner Multum)
  • Feldene Advanced Consumer Information (Micromedex)
  • Feldene AHFS DI Monographs (ASHP)
  • Piroxicam Consumer Information (Wolters Kluwer)
  • Piroxicam Consumer Information (Cerner Multum)
  • Alti-Piroxicam Advanced Consumer Information (Micromedex)
  • Piroxicam Advanced Consumer Information (Micromedex)
  • Piroxicam AHFS DI Monographs (ASHP)

Onetic 4




Onetic 4 may be available in the countries listed below.


Ingredient matches for Onetic 4



Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Onetic 4 in the following countries:


  • Indonesia

International Drug Name Search


Nurofentabs




Nurofentabs may be available in the countries listed below.


Ingredient matches for Nurofentabs



Ibuprofen

Ibuprofen is reported as an ingredient of Nurofentabs in the following countries:


  • France

International Drug Name Search


Sincrover




Sincrover may be available in the countries listed below.


Ingredient matches for Sincrover



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Sincrover in the following countries:


  • Italy

International Drug Name Search


Sorogenta-Solucao Intramamaria




Sorogenta-Solucao Intramamaria may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sorogenta-Solucao Intramamaria



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Sorogenta-Solucao Intramamaria in the following countries:


  • Portugal

International Drug Name Search


Thursday, October 27, 2016

Nicotinex




In the US, Nicotinex (niacin systemic) is a member of the following drug classes: miscellaneous antihyperlipidemic agents, vitamins and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL, Niacin Deficiency and Pellagra.

US matches:

  • Nicotinex

Ingredient matches for Nicotinex



Nicotinic Acid

Nicotinic Acid is reported as an ingredient of Nicotinex in the following countries:


  • United States

International Drug Name Search


Nitroretard Faran




Nitroretard Faran may be available in the countries listed below.


Ingredient matches for Nitroretard Faran



Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitroretard Faran in the following countries:


  • Greece

International Drug Name Search


Hermolepsin




Hermolepsin may be available in the countries listed below.


Ingredient matches for Hermolepsin



Carbamazepine

Carbamazepine is reported as an ingredient of Hermolepsin in the following countries:


  • Sweden

International Drug Name Search


Vesikur




Vesikur may be available in the countries listed below.


Ingredient matches for Vesikur



Solifenacin

Solifenacin succinate (a derivative of Solifenacin) is reported as an ingredient of Vesikur in the following countries:


  • Germany

International Drug Name Search


Wednesday, October 26, 2016

Haloperidol Vannier




Haloperidol Vannier may be available in the countries listed below.


Ingredient matches for Haloperidol Vannier



Haloperidol

Haloperidol is reported as an ingredient of Haloperidol Vannier in the following countries:


  • Argentina

International Drug Name Search


Venosmine




Venosmine may be available in the countries listed below.


Ingredient matches for Venosmine



Diosmin

Diosmin is reported as an ingredient of Venosmine in the following countries:


  • Italy

International Drug Name Search


Nootropyl




Nootropyl may be available in the countries listed below.


Ingredient matches for Nootropyl



Piracetam

Piracetam is reported as an ingredient of Nootropyl in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Chile

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Mauritius

  • Niger

  • Senegal

  • Togo

  • Tunisia

  • Vietnam

  • Zaire

International Drug Name Search


Olux


Olux is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):


OLUX (clobetasol propionate - aerosol, foam; topical)



  • Manufacturer: STIEFEL LABS INC

    Approval date: May 26, 2000

    Strength(s): 0.05% [RLD][AB]

Has a generic version of Olux been approved?


A generic version of Olux has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Olux and have been approved by the FDA:


clobetasol propionate aerosol, foam; topical



  • Manufacturer: PERRIGO ISRAEL

    Approval date: March 10, 2008

    Strength(s): 0.05% [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Olux. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
    Patent 6,126,920
    Issued: October 3, 2000
    Inventor(s): Jones; Julie Irene & Baker; Anthony Richard & Halls; Neil Graham & Watmough; Peter & Marriott; Peter
    Assignee(s): Medeva Europe PLC
    Methods of treating various skin diseases, and in particular, scalp psoriasis, utilizing a foamable pharmaceutical composition comprising a corticosteroid active substance, a quick-break foaming agent, a propellant and a buffering agent are disclosed. The quick-break foaming agent typically comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent.
    Patent expiration dates:

    • March 1, 2016
      ✓ 
      Patent use: METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION



See also...

  • Olux Foam Consumer Information (Wolters Kluwer)
  • Olux Consumer Information (Cerner Multum)
  • Olux Advanced Consumer Information (Micromedex)
  • Clobetasol Cream Consumer Information (Wolters Kluwer)
  • Clobetasol Emollient Foam Consumer Information (Wolters Kluwer)
  • Clobetasol Foam Consumer Information (Wolters Kluwer)
  • Clobetasol Gel Consumer Information (Wolters Kluwer)
  • Clobetasol Lotion Consumer Information (Wolters Kluwer)
  • Clobetasol Shampoo Consumer Information (Wolters Kluwer)
  • Clobetasol Solution Consumer Information (Wolters Kluwer)
  • Clobetasol Spray Consumer Information (Wolters Kluwer)
  • Clobetasol topical Consumer Information (Cerner Multum)
  • Clobetasol Propionate Advanced Consumer Information (Micromedex)
  • Med Clobetasol Scalp Application Advanced Consumer Information (Micromedex)
  • Ratio-Clobetasol Advanced Consumer Information (Micromedex)
  • Clobetasol Topical application Advanced Consumer Information (Micromedex)
  • Clobetasol Propionate AHFS DI Monographs (ASHP)

Dintoinale




Dintoinale may be available in the countries listed below.


Ingredient matches for Dintoinale



Methylphenobarbital

Methylphenobarbital is reported as an ingredient of Dintoinale in the following countries:


  • Italy

Phenytoin

Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Dintoinale in the following countries:


  • Italy

International Drug Name Search


Oxifenciclimina




Oxifenciclimina may be available in the countries listed below.


Ingredient matches for Oxifenciclimina



Oxyphencyclimine

Oxifenciclimina (DCIT) is also known as Oxyphencyclimine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Deflatop




Deflatop may be available in the countries listed below.


Ingredient matches for Deflatop



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Deflatop in the following countries:


  • Germany

International Drug Name Search


Atley Pharmaceuticals


Address


Atley Pharmaceuticals,
10511 Old Ridge Road

Ashland, Virginia 23005

Contact Details

Phone: (804) 227-2250
Website: http://www.atley.com/
Careers: http://www.atley.com/careers.asp

Neo Sol




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Neo Sol



Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Neo Sol in the following countries:


  • United States

International Drug Name Search


Tuesday, October 25, 2016

Dopamine Hydrochloride in Dextrose




Ingredient matches for Dopamine Hydrochloride in Dextrose



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamine Hydrochloride in Dextrose in the following countries:


  • Canada

  • United States

International Drug Name Search


Zinsul




Zinsul may be available in the countries listed below.


Ingredient matches for Zinsul



Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Zinsul in the following countries:


  • Bangladesh

International Drug Name Search


Spiritus Salicylicus




Spiritus Salicylicus may be available in the countries listed below.


Ingredient matches for Spiritus Salicylicus



Salicylic Acid

Salicylic Acid is reported as an ingredient of Spiritus Salicylicus in the following countries:


  • Bulgaria

International Drug Name Search


Delta Albaplex




Delta Albaplex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Delta Albaplex



Novobiocin

Novobiocin sodium salt (a derivative of Novobiocin) is reported as an ingredient of Delta Albaplex in the following countries:


  • Australia

Prednisolone

Prednisolone is reported as an ingredient of Delta Albaplex in the following countries:


  • Australia

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Delta Albaplex in the following countries:


  • Australia

International Drug Name Search


Diclox




Diclox may be available in the countries listed below.


Ingredient matches for Diclox



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclox in the following countries:


  • Bangladesh

International Drug Name Search


Antihyperuricemic agents


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Antihyperuricemic agents are also called antigout agents. These agents work to either correct overproduction or underexcretion of uric acid.


For the long term control of gout, hyperuricemia caused by formation of uric acid from purines, can be effectively controlled with these agents. The choice of xanthine oxidase inhibitors or uricosuric medicines is based on the level of urinary uric acid excretion, renal function, age of the patient, history of renal calculi and presence of tophi.

See also

Medical conditions associated with antihyperuricemic agents:

  • Calcium Oxalate Calculi with Hyperuricosuria
  • Cardiothoracic Surgery
  • Gout
  • Heart Failure
  • High Risk Percutaneous Transluminal Angioplasty
  • Hyperuricemia Secondary to Chemotherapy
  • Leishmaniasis
  • Mania
  • Reactive Perforating Collangenosis
  • Urinary Tract Stones

Drug List:


Monday, October 24, 2016

Actonel


Actonel is a brand name of risedronate, approved by the FDA in the following formulation(s):


ACTONEL (risedronate sodium - tablet; oral)



  • Manufacturer: WARNER CHILCOTT

    Approval date: March 27, 1998

    Strength(s): 30MG [AB]


  • Manufacturer: WARNER CHILCOTT

    Approval date: April 14, 2000

    Strength(s): 5MG [AB]


  • Manufacturer: WARNER CHILCOTT

    Approval date: May 25, 2002

    Strength(s): 35MG [RLD][AB]


  • Manufacturer: WARNER CHILCOTT

    Approval date: April 22, 2008

    Strength(s): 150MG [RLD]

Has a generic version of Actonel been approved?


A generic version of Actonel has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Actonel and have been approved by the FDA:


risedronate sodium tablet; oral



  • Manufacturer: TEVA PHARMS

    Approval date: October 5, 2007

    Strength(s): 30MG [AB], 35MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Actonel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pharmaceutical compositions containing geminal diphosphonates
    Patent 5,583,122
    Issued: December 10, 1996
    Inventor(s): Benedict; James J. & Perkins; Christopher M.
    Assignee(s): The Procter & Gamble Company
    Pharmaceutical compositions, useful for treating abnormal calcium and phosphate metabolism, which contain geminal-diphosphonic acid compounds; and a method of treating diseases characterized by abnormal calcium and phosphate metabolism utilizing these pharmaceutical compositions.
    Patent expiration dates:

    • December 10, 2013
      ✓ 
      Patent use: METHOD OF TREATING PAGET'S DISEASE USING ACTONEL


    • December 10, 2013
      ✓ 
      Patent use: ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • December 10, 2013
      ✓ 
      Patent use: METHOD OF TREATING PAGET'S DISEASE USING ACTONEL
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • December 10, 2013
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF OSTEOPOROSIS
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • June 10, 2014
      ✓ 
      Pediatric exclusivity




  • Method for inhibiting bone resorption
    Patent 5,994,329
    Issued: November 30, 1999
    Inventor(s): Daifotis; Anastasia G. & Santora, II; Arthur C. & Yates; A. John
    Assignee(s): Merck & Co., Inc.
    Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
    Patent expiration dates:

    • July 17, 2018
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF OSTEOPOROSIS


    • January 17, 2019
      ✓ 
      Pediatric exclusivity




  • Method for inhibiting bone resorption
    Patent 6,015,801
    Issued: January 18, 2000
    Inventor(s): Daifotis; Anastasia G. & Yates; A. John & Santora, II; Arthur C.
    Assignee(s): Merck & Co., Inc.
    Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for caring out the therapeutic methods disclosed herein.
    Patent expiration dates:

    • July 17, 2018
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF OSTEOPOROSIS


    • January 17, 2019
      ✓ 
      Pediatric exclusivity




  • Dosage forms of risedronate
    Patent 6,096,342
    Issued: August 1, 2000
    Inventor(s): Dansereau; Richard John & Mosher; Russell Youker & Axelrod; Douglas Wayne & Sietsema; William Kendall
    Assignee(s): The Procter & Gamble Company
    The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical compostion which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower intestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which sometimes accompanies the oral administration of risedronate active ingredients.
    Patent expiration dates:

    • November 22, 2011


    • November 22, 2011
      ✓ 
      Drug product


    • November 22, 2011
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF OSTEOPOROSIS
      ✓ 
      Drug product


    • May 22, 2012
      ✓ 
      Pediatric exclusivity




  • Film-coated tablet for improved upper gastrointestinal tract safety
    Patent 6,165,513
    Issued: December 26, 2000
    Inventor(s): Dansereau; Richard John & Bekker; Petrus Jakobus
    Assignee(s): The Procter & Gamble Co.
    A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidine, nonsteroidal anti-inflammatory drugs, alprenolol, ascorbic acid, captopril, theophylline, zidovoudine (AZT), bisphosphonates and mixtures thereof and pharmaceutically-acceptable excipients, wherein said oral dosage form is a generally oval form and film coated to facilitate rapid esophageal transit and avoid irritation in the mouth, buccal cavity, pharynx, and esophagus.
    Patent expiration dates:

    • June 10, 2018


    • June 10, 2018
      ✓ 
      Drug product


    • December 10, 2018
      ✓ 
      Pediatric exclusivity




  • Method for inhibiting bone resorption
    Patent 6,432,932
    Issued: August 13, 2002
    Inventor(s): Anastasia G.; Daifotis & Arthur C.; Santora, II & A. John; Yates
    Assignee(s): Merck & Co., Inc.
    Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
    Patent expiration dates:

    • July 17, 2018
      ✓ 
      Patent use: 35 MG ORALLY ONCE A WEEK FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN; 35 MG ORALLY ONCE A WEEK FOR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN


    • January 17, 2019
      ✓ 
      Pediatric exclusivity




  • Method for inhibiting bone resorption
    Patent 6,465,443
    Issued: October 15, 2002
    Inventor(s): Anastasia G.; Daifotis & Arthur C.; Santora, II & A. John; Yates
    Assignee(s): Merck & Co., Inc.
    Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
    Patent expiration dates:

    • August 14, 2018
      ✓ 
      Drug product


    • February 14, 2019
      ✓ 
      Pediatric exclusivity




  • Method of treatment using bisphosphonic acid
    Patent 7,192,938
    Issued: March 20, 2007
    Inventor(s): Bauss; Frieder & Pichler; Bernhard & Turley; Stephen
    Assignee(s): Hoffmann-La Roche Inc.
    The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
    Patent expiration dates:

    • May 6, 2023
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF OSTEOPOROSIS


    • November 6, 2023
      ✓ 
      Pediatric exclusivity




  • Method of treatment using bisphosphonic acid
    Patent 7,718,634
    Issued: May 18, 2010
    Inventor(s): Bauss; Frieder & Pichler; Bernhard & Turley; Stephen
    Assignee(s): Hoffman-La Roche Inc.
    The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
    Patent expiration dates:

    • May 6, 2023
      ✓ 
      Patent use: TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN


    • November 6, 2023
      ✓ 
      Pediatric exclusivity



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 16, 2010 - PEDIATRIC EXCLUSIVITY

    • April 22, 2011 - NEW STRENGTH

    • October 22, 2011 - PEDIATRIC EXCLUSIVITY

    • July 23, 2012 - REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST

    • January 23, 2013 - PEDIATRIC EXCLUSIVITY

See also...

  • Actonel Consumer Information (Drugs.com)
  • Actonel Consumer Information (Wolters Kluwer)
  • Actonel Consumer Information (Cerner Multum)
  • Actonel Advanced Consumer Information (Micromedex)
  • Actonel AHFS DI Monographs (ASHP)
  • Risedronate Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Risedronate Tablets Consumer Information (Wolters Kluwer)
  • Risedronate Consumer Information (Cerner Multum)
  • Risedronate Advanced Consumer Information (Micromedex)
  • Risedronate Sodium AHFS DI Monographs (ASHP)

Silvadene


Silvadene is a brand name of silver sulfadiazine topical, approved by the FDA in the following formulation(s):


SILVADENE (silver sulfadiazine - cream; topical)



  • Manufacturer: KING PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 1% [RLD][AB]

Has a generic version of Silvadene been approved?


Yes. The following products are equivalent to Silvadene:


SSD (silver sulfadiazine cream; topical)



  • Manufacturer: DR REDDYS LA

    Approval date: February 25, 1982

    Strength(s): 1% [AB]

THERMAZENE (silver sulfadiazine cream; topical)



  • Manufacturer: COVIDIEN

    Approval date: December 23, 1985

    Strength(s): 1% [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Silvadene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Silvadene.

See also...

  • Silvadene Consumer Information (Wolters Kluwer)
  • Silvadene Consumer Information (Cerner Multum)
  • Silvadene Topical Advanced Consumer Information (Micromedex)
  • Silver Sulfadiazine Consumer Information (Wolters Kluwer)
  • Silver sulfadiazine topical Consumer Information (Cerner Multum)
  • Flamazine Topical Advanced Consumer Information (Micromedex)
  • Silver sulfadiazine Topical Advanced Consumer Information (Micromedex)
  • Silver Sulfadiazine AHFS DI Monographs (ASHP)

Depo-Medrol + Lidocaina




Depo-Medrol + Lidocaina may be available in the countries listed below.


Ingredient matches for Depo-Medrol + Lidocaina



Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Depo-Medrol + Lidocaina in the following countries:


  • Belgium

  • Italy

Methylprednisolone

Methylprednisolone 21-acetate (a derivative of Methylprednisolone) is reported as an ingredient of Depo-Medrol + Lidocaina in the following countries:


  • Belgium

  • Italy

International Drug Name Search


Syscor




Syscor may be available in the countries listed below.


UK matches:

  • Syscor MR 10 (SPC)

Ingredient matches for Syscor



Nisoldipine

Nisoldipine is reported as an ingredient of Syscor in the following countries:


  • Austria

  • Belgium

  • Finland

  • Greece

  • Guyana

  • Italy

  • Luxembourg

  • Spain

  • Taiwan

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Opiclam




Opiclam may be available in the countries listed below.


Ingredient matches for Opiclam



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Opiclam in the following countries:


  • Indonesia

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Opiclam in the following countries:


  • Indonesia

International Drug Name Search


Valecid




Valecid may be available in the countries listed below.


Ingredient matches for Valecid



Cefonicid

Cefonicid disodium salt (a derivative of Cefonicid) is reported as an ingredient of Valecid in the following countries:


  • Italy

International Drug Name Search


Diclofenac Hexa




Diclofenac Hexa may be available in the countries listed below.


Ingredient matches for Diclofenac Hexa



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Hexa in the following countries:


  • Argentina

International Drug Name Search


Novirell B12




Novirell B12 may be available in the countries listed below.


Ingredient matches for Novirell B12



Cyanocobalamin

Cyanocobalamin is reported as an ingredient of Novirell B12 in the following countries:


  • Germany

International Drug Name Search


Deanol




Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

N06BX04

CAS registry number (Chemical Abstracts Service)

0000108-01-0

Chemical Formula

C4-H11-N-O

Molecular Weight

89

Therapeutic Categories

Central stimulant

Cholinergic

Chemical Name

Ethanol, 2-(dimethylamino)-

Foreign Names

  • Deanol (German)
  • Demanol (French)

Generic Names

  • Deanol (OS: BAN)
  • Démanol (OS: DCF)
  • DMAE (IS)
  • Démanol (acéglutamate de) (OS: DCF)
  • CR 121 (IS)
  • Deanol N-acetylhydrogenglutamate (IS)
  • Deanol pyroglutamate (IS)
  • Deanol hemisuccinate (IS)

Brand Names

  • Bimanol
    Polfa Pabianice, Poland


  • Clérégil
    Merck-Clévenot, France


  • Nooclerin
    Pik-Pharma, Russian Federation


  • Risatarun
    Ravensberg, Germany


  • Débrumyl (Deanol and Heptaminol)
    Pierre Fabre, Portugal; Pierre Fabre Médicament, France


  • Denubil (Deanol and Heptaminol)
    Pierre Fabre, Spain


  • Tonibral
    Bouchara, Luxembourg; Sandoz, Portugal

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Nu-Divalproex




Nu-Divalproex may be available in the countries listed below.


Ingredient matches for Nu-Divalproex



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Nu-Divalproex in the following countries:


  • Canada

International Drug Name Search


Hidroxiurea




Hidroxiurea may be available in the countries listed below.


Ingredient matches for Hidroxiurea



Hydroxycarbamide

Hydroxycarbamide is reported as an ingredient of Hidroxiurea in the following countries:


  • Venezuela

International Drug Name Search


Sunday, October 23, 2016

Dobenzic




Dobenzic may be available in the countries listed below.


Ingredient matches for Dobenzic



Cobamamide

Cobamamide is reported as an ingredient of Dobenzic in the following countries:


  • Vietnam

International Drug Name Search


Hexa-Blok




Hexa-Blok may be available in the countries listed below.


Ingredient matches for Hexa-Blok



Atenolol

Atenolol is reported as an ingredient of Hexa-Blok in the following countries:


  • South Africa

International Drug Name Search


Neurofen




Neurofen may be available in the countries listed below.


Ingredient matches for Neurofen



Ibuprofen

Ibuprofen is reported as an ingredient of Neurofen in the following countries:


  • Bangladesh

  • Ireland

International Drug Name Search


Sergeants Worm Away




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sergeants Worm Away



Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Sergeants Worm Away in the following countries:


  • United States

International Drug Name Search


Diclofenac sódico Calox




Diclofenac sódico Calox may be available in the countries listed below.


Ingredient matches for Diclofenac sódico Calox



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac sódico Calox in the following countries:


  • Venezuela

International Drug Name Search


Dilatam




Dilatam may be available in the countries listed below.


Ingredient matches for Dilatam



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilatam in the following countries:


  • Israel

  • Latvia

International Drug Name Search


Saturday, October 22, 2016

Zenesten




Zenesten may be available in the countries listed below.


Ingredient matches for Zenesten



Clotrimazole

Clotrimazole is reported as an ingredient of Zenesten in the following countries:


  • Bangladesh

International Drug Name Search


Dilta-Hexal




Dilta-Hexal may be available in the countries listed below.


Ingredient matches for Dilta-Hexal



Diltiazem

Diltiazem is reported as an ingredient of Dilta-Hexal in the following countries:


  • Luxembourg

International Drug Name Search


Nervus




Nervus may be available in the countries listed below.


Ingredient matches for Nervus



Alprazolam

Alprazolam is reported as an ingredient of Nervus in the following countries:


  • Dominican Republic

International Drug Name Search


Ofloxacine Teva




Ofloxacine Teva may be available in the countries listed below.


Ingredient matches for Ofloxacine Teva



Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacine Teva in the following countries:


  • Belgium

  • France

International Drug Name Search


Skinoren




Skinoren may be available in the countries listed below.


UK matches:

  • Skinoren Cream (SPC)

Ingredient matches for Skinoren



Azelaic Acid

Azelaic Acid is reported as an ingredient of Skinoren in the following countries:


  • Austria

  • Bahrain

  • Belgium

  • Bosnia & Herzegowina

  • Bulgaria

  • Croatia (Hrvatska)

  • Cyprus

  • Czech Republic

  • Denmark

  • Egypt

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • Iraq

  • Ireland

  • Italy

  • Jordan

  • Kuwait

  • Latvia

  • Lebanon

  • Libya

  • Lithuania

  • Luxembourg

  • Malta

  • New Zealand

  • Norway

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovenia

  • South Africa

  • Spain

  • Sudan

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, October 21, 2016

Vancomycin Merck




Vancomycin Merck may be available in the countries listed below.


Ingredient matches for Vancomycin Merck



Vancomycin

Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Vancomycin Merck in the following countries:


  • Israel

International Drug Name Search


Quidorfen




Quidorfen may be available in the countries listed below.


Ingredient matches for Quidorfen



Fentanyl

Fentanyl is reported as an ingredient of Quidorfen in the following countries:


  • Spain

International Drug Name Search


Stavubergen




Stavubergen may be available in the countries listed below.


Ingredient matches for Stavubergen



Stavudine

Stavudine is reported as an ingredient of Stavubergen in the following countries:


  • Argentina

International Drug Name Search


Stigmin




Stigmin may be available in the countries listed below.


Ingredient matches for Stigmin



Neostigmine

Neostigmine bromide (a derivative of Neostigmine) is reported as an ingredient of Stigmin in the following countries:


  • Bangladesh

International Drug Name Search


Simvastatina Edigen




Simvastatina Edigen may be available in the countries listed below.


Ingredient matches for Simvastatina Edigen



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Edigen in the following countries:


  • Spain

International Drug Name Search


Desmopressin Teva




Desmopressin Teva may be available in the countries listed below.


Ingredient matches for Desmopressin Teva



Desmopressin

Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of Desmopressin Teva in the following countries:


  • Germany

  • Slovakia

International Drug Name Search


Nimotas




Nimotas may be available in the countries listed below.


Ingredient matches for Nimotas



Nimesulide

Nimesulide is reported as an ingredient of Nimotas in the following countries:


  • Georgia

  • Myanmar

  • Peru

International Drug Name Search


Singlauc




Singlauc may be available in the countries listed below.


Ingredient matches for Singlauc



Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Singlauc in the following countries:


  • Argentina

International Drug Name Search


Spectam




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Spectam



Spectinomycin

Spectinomycin dihydrochloride (a derivative of Spectinomycin) is reported as an ingredient of Spectam in the following countries:


  • Belgium

  • France

  • Germany

  • Ireland

  • Netherlands

  • Portugal

  • United Kingdom

  • United States

International Drug Name Search


Venocap




Venocap may be available in the countries listed below.


Ingredient matches for Venocap



Calcium Dobesilate

Calcium Dobesilate is reported as an ingredient of Venocap in the following countries:


  • Peru

International Drug Name Search


Simvastatina Premium Pharma




Simvastatina Premium Pharma may be available in the countries listed below.


Ingredient matches for Simvastatina Premium Pharma



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Premium Pharma in the following countries:


  • Spain

International Drug Name Search


Vibral




Vibral may be available in the countries listed below.


Ingredient matches for Vibral



Dropropizine

Dropropizine is reported as an ingredient of Vibral in the following countries:


  • Brazil

International Drug Name Search


Small Intestine Intubation Medications


Drugs associated with Small Intestine Intubation

The following drugs and medications are in some way related to, or used in the treatment of Small Intestine Intubation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Thursday, October 20, 2016

Diuresin




Diuresin may be available in the countries listed below.


Ingredient matches for Diuresin



Indapamide

Indapamide is reported as an ingredient of Diuresin in the following countries:


  • Poland

International Drug Name Search


Zorbtive




In the US, Zorbtive (somatropin systemic) is a member of the drug class growth hormones and is used to treat Short Bowel Syndrome and Short Stature for Age.

US matches:

  • Zorbtive

Ingredient matches for Zorbtive



Somatropine

Somatropine is reported as an ingredient of Zorbtive in the following countries:


  • United States

International Drug Name Search


Selegilin-Teva




Selegilin-Teva may be available in the countries listed below.


Ingredient matches for Selegilin-Teva



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Selegilin-Teva in the following countries:


  • Germany

International Drug Name Search


Neoxazol




Neoxazol may be available in the countries listed below.


Ingredient matches for Neoxazol



Sulfafurazole

Sulfafurazole is reported as an ingredient of Neoxazol in the following countries:


  • Romania

International Drug Name Search


Diazépam




Diazépam may be available in the countries listed below.


Ingredient matches for Diazépam



Diazepam

Diazépam (DCF) is known as Diazepam in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Ubequinon




Ubequinon may be available in the countries listed below.


Ingredient matches for Ubequinon



Ubidecarenone

Ubidecarenone is reported as an ingredient of Ubequinon in the following countries:


  • Japan

International Drug Name Search


Wednesday, October 19, 2016

Nimorazole




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01AB06

CAS registry number (Chemical Abstracts Service)

0006506-37-2

Chemical Formula

C9-H14-N4-O3

Molecular Weight

226

Therapeutic Category

Antiprotozoal agent: Trichomonacidal

Chemical Name

Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-

Foreign Names

  • Nimorazolum (Latin)
  • Nimorazol (German)
  • Nimorazole (French)
  • Nimorazol (Spanish)

Generic Names

  • Nimorazole (OS: BAN, DCF)
  • Nimorazolo (OS: DCIT)
  • K 1900 (IS)
  • Nitrimidazine (IS)
  • Nimorazolo (PH: F.U. XII)

Brand Names

  • Naxogin
    Pfizer, Belgium; Pfizer, Brazil; Pfizer, Chile; Pfizer, Peru; Pfizer, Russian Federation; Pharmacia, Georgia; Pharmacia, Ghana; Pharmacia, Kenya; Pharmacia, Liberia; Pharmacia, Luxembourg; Pharmacia, Sierra Leone; Pharmacia, Tanzania; Pharmacia, Uganda; Pharmacia, Zimbabwe; Pharmacia Upjohn, Oman; Rontag, Argentina

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sera baktopur direct




Sera baktopur direct may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sera baktopur direct



Nifurpirinol

Nifurpirinol is reported as an ingredient of Sera baktopur direct in the following countries:


  • Switzerland

International Drug Name Search


Dexbru




Dexbru may be available in the countries listed below.


Ingredient matches for Dexbru



Dexibuprofen

Dexibuprofen is reported as an ingredient of Dexbru in the following countries:


  • Bangladesh

International Drug Name Search


Diklofenak Merck NM




Diklofenak Merck NM may be available in the countries listed below.


Ingredient matches for Diklofenak Merck NM



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diklofenak Merck NM in the following countries:


  • Denmark

International Drug Name Search


Decabolon




Decabolon may be available in the countries listed below.


Ingredient matches for Decabolon



Nandrolone

Nandrolone 17ß-decanoate (a derivative of Nandrolone) is reported as an ingredient of Decabolon in the following countries:


  • Bangladesh

International Drug Name Search


Azulfidine EN-tabs


See also: Generic Azulfidine


Azulfidine EN-tabs is a brand name of sulfasalazine, approved by the FDA in the following formulation(s):


AZULFIDINE EN-TABS (sulfasalazine - tablet, delayed release; oral)



  • Manufacturer: PHARMACIA AND UPJOHN

    Approval date: April 6, 1983

    Strength(s): 500MG [RLD][AB]

Has a generic version of Azulfidine EN-tabs been approved?


Yes. The following products are equivalent to Azulfidine EN-tabs:


sulfasalazine tablet, delayed release; oral



  • Manufacturer: VINTAGE PHARMS

    Approval date: January 11, 2002

    Strength(s): 500MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Azulfidine EN-tabs. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Azulfidine EN-tabs.

See also...

  • Azulfidine EN-tabs Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Azulfidine EN-tabs Consumer Information (Cerner Multum)
  • Azulfidine Entabs Oral, Rectal Advanced Consumer Information (Micromedex)
  • Sulfasalazine Consumer Information (Wolters Kluwer)
  • Sulfasalazine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Sulfasalazine Consumer Information (Cerner Multum)
  • Alti-Sulfasalazine Oral, Rectal Advanced Consumer Information (Micromedex)
  • Salazopyrin Oral, Rectal Advanced Consumer Information (Micromedex)
  • Sulfasalazine Oral, Rectal Advanced Consumer Information (Micromedex)
  • Sulfasalazine AHFS DI Monographs (ASHP)

Idiopathic Thrombocytopenic Purpura Medications


Drugs associated with Idiopathic Thrombocytopenic Purpura

The following drugs and medications are in some way related to, or used in the treatment of Idiopathic Thrombocytopenic Purpura. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Idiopathic Thrombocytopenic Purpura





Drug List:


Valosine




Valosine may be available in the countries listed below.


Ingredient matches for Valosine



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Valosine in the following countries:


  • Taiwan

International Drug Name Search


Neurobion




In the US, Neurobion is a member of the drug class vitamin and mineral combinations and is used to treat Dietary Supplementation.

Ingredient matches for Neurobion



Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Neurobion in the following countries:


  • Germany

Thiamine

Thiamine disulfide (a derivative of Thiamine) is reported as an ingredient of Neurobion in the following countries:


  • Germany

International Drug Name Search


Tuesday, October 18, 2016

Septopal




In the US, Septopal is a member of the drug class aminoglycosides and is used to treat Bacteremia, Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Brucellosis, Burns - External, Cystic Fibrosis, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Meningitis, Pelvic Inflammatory Disease, Peritonitis, Plague, Pneumonia, Rabbit Fever, Skin Infection and Surgical Prophylaxis.

Ingredient matches for Septopal



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Septopal in the following countries:


  • Australia

  • Austria

  • Belgium

  • Finland

  • Germany

  • Hungary

  • India

  • Luxembourg

  • Netherlands

  • Norway

  • South Africa

  • Switzerland

  • Thailand

International Drug Name Search


Oxfendex




Oxfendex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxfendex



Oxfendazole

Oxfendazole is reported as an ingredient of Oxfendex in the following countries:


  • Ireland

International Drug Name Search


Doxy




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Doxy



Doxycycline

Doxycycline is reported as an ingredient of Doxy in the following countries:


  • Bahrain

  • Cyprus

  • Kuwait

  • Lebanon

  • Luxembourg

  • Peru

  • Qatar

  • Saudi Arabia

  • Syria

  • Tunisia

  • United Arab Emirates

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxy in the following countries:


  • France

  • Israel

  • Netherlands

  • Oman

  • United States

Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxy in the following countries:


  • Australia

  • New Zealand

International Drug Name Search


Suanovil




Suanovil may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Suanovil



Spiramycin

Spiramycin is reported as an ingredient of Suanovil in the following countries:


  • Belgium

  • France

  • Luxembourg

  • Netherlands

  • Portugal

  • Switzerland

Spiramycin adipate (a derivative of Spiramycin) is reported as an ingredient of Suanovil in the following countries:


  • France

International Drug Name Search


Herpial




Herpial may be available in the countries listed below.


Ingredient matches for Herpial



Acyclovir

Aciclovir is reported as an ingredient of Herpial in the following countries:


  • Spain

International Drug Name Search


Uriduct




Uriduct may be available in the countries listed below.


Ingredient matches for Uriduct



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Uriduct in the following countries:


  • Germany

International Drug Name Search


Sodium Stibogluconate




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01CB02

CAS registry number (Chemical Abstracts Service)

0016037-91-5

Chemical Formula

C12-H17-Na3-O17-Sb2·9H2O

Molecular Weight

907

Therapeutic Category

Antiprotozoal agent, leishmaniocidal

Chemical Name

D-Gluconic acid, 2,4:2',4'-O-(oxydistibylidyne)bis-, Sb,Sb'-dioxide, trisodium salt, nonahydrate

Foreign Names

  • Natrii stibogluconas (Latin)
  • Natrium stibogluconat (German)
  • Stibogluconate de sodium (French)
  • Estibogluconato sodico (Spanish)

Generic Names

  • Sodium Stibogluconate (OS: BAN)
  • Stibogluconate sodique (OS: DCF)
  • Natriumstibogluconat-9-Wasser (IS)
  • Solusurmin (IS)
  • Stibogluconat (IS)
  • Natrii stibogluconas (PH: Ph. Int. 4)
  • Sodio stibogluconato (PH: F.U. XII)
  • Sodium Stibogluconate (PH: Ph. Int. 4, BP 2010)

Brand Names

  • Pentostam
    GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Bahrain; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Israel; GlaxoSmithKline, Iran; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Oman; GlaxoSmithKline, Qatar


  • Pentostam (veterinary use)
    GlaxoSmithKline, United Kingdom


  • Sodio Stibogluconato
    Salf, Italy


  • Stibatin
    GlaxoSmithKline, Bangladesh


  • Stiboson
    Jayson, Bangladesh

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dormex




Dormex may be available in the countries listed below.


Ingredient matches for Dormex



Brotizolam

Brotizolam is reported as an ingredient of Dormex in the following countries:


  • Chile

Eszopiclone

Zopiclone is reported as an ingredient of Dormex in the following countries:


  • Peru

International Drug Name Search


Serseitran




Serseitran may be available in the countries listed below.


Ingredient matches for Serseitran



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Serseitran in the following countries:


  • Spain

International Drug Name Search


Sandoz Anagrelide




Sandoz Anagrelide may be available in the countries listed below.


Ingredient matches for Sandoz Anagrelide



Anagrelide

Anagrelide hydrochloride (a derivative of Anagrelide) is reported as an ingredient of Sandoz Anagrelide in the following countries:


  • Canada

International Drug Name Search


Monday, October 17, 2016

Zostex




Zostex may be available in the countries listed below.


Ingredient matches for Zostex



Brivudine

Brivudine is reported as an ingredient of Zostex in the following countries:


  • Austria

  • Germany

  • Turkey

International Drug Name Search


Mycelex


Mycelex is a brand name of clotrimazole topical, approved by the FDA in the following formulation(s):


MYCELEX (clotrimazole - solution; topical)



  • Manufacturer: BAYER HLTHCARE

    Approved Prior to Jan 1, 1982

    Strength(s): 1% [RLD][AT]

Has a generic version of Mycelex been approved?


Yes. The following products are equivalent to Mycelex:


clotrimazole solution; topical



  • Manufacturer: TARO

    Approval date: July 29, 1996

    Strength(s): 1% [AT]


  • Manufacturer: TEVA

    Approval date: February 28, 1995

    Strength(s): 1% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mycelex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Mycelex.

See also...

  • Mycelex Cream Consumer Information (Wolters Kluwer)
  • Mycelex Troches Consumer Information (Wolters Kluwer)
  • Mycelex-7 Combo Pack Cream Consumer Information (Wolters Kluwer)
  • Mycelex-7 Cream Consumer Information (Wolters Kluwer)
  • Mycelex-7 Inserts Consumer Information (Wolters Kluwer)
  • Mycelex Consumer Information (Cerner Multum)
  • Mycelex Topical Advanced Consumer Information (Micromedex)
  • Clotrimazole Cream Consumer Information (Wolters Kluwer)
  • Clotrimazole Inserts Consumer Information (Wolters Kluwer)
  • Clotrimazole Lotion Consumer Information (Wolters Kluwer)
  • Clotrimazole Solution Consumer Information (Wolters Kluwer)
  • Clotrimazole Troches Consumer Information (Wolters Kluwer)
  • Anti-Fungal Liquid Consumer Information (Cerner Multum)
  • Fungoid Solution Consumer Information (Cerner Multum)
  • Lotrimin AF Solution Consumer Information (Cerner Multum)
  • Lotrimin Jock Itch Powder Consumer Information (Cerner Multum)
  • MPM Anti-Fungal Consumer Information (Cerner Multum)
  • Mycelex-G Consumer Information (Cerner Multum)
  • Prescription Strength Cruex Consumer Information (Cerner Multum)
  • Clotrimazole topical Consumer Information (Cerner Multum)
  • Clotrimazole vaginal Consumer Information (Cerner Multum)
  • Clotrim Antifungal Topical Advanced Consumer Information (Micromedex)
  • Clotrimaderm Topical Advanced Consumer Information (Micromedex)
  • Cruex Prescription Strength Topical Advanced Consumer Information (Micromedex)
  • Desenex Topical Advanced Consumer Information (Micromedex)
  • Myclo-Derm Topical Advanced Consumer Information (Micromedex)
  • Neo-Zol Topical Advanced Consumer Information (Micromedex)
  • Clotrimazole Topical Advanced Consumer Information (Micromedex)
  • Clotrimazole AHFS DI Monographs (ASHP)